What is the proposed valuation and offer structure for Tate & Lyle in Ingredion's takeover bid?

The proposed takeover values Tate & Lyle at 2.74 billion pounds ($3.70 billion), with shareholders set to receive up to 615 pence per share — comprising 595 pence in cash and up to 20 pence in dividends — representing a 64% premium to its May 13 closing price.

Has Ingredion made a firm offer for Tate & Lyle, and what does Tate & Lyle say about the status of discussions?

No firm offer has been made; Tate & Lyle stated it is 'in discussions' with Ingredion following 'a number of earlier approaches', but emphasized there is 'no certainty' that a formal offer will be forthcoming.

Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid

May 14, 2026

Tate & Lyle confirmed discussions with U.S. rival Ingredion for a $3.7 billion takeover, valuing the firm at £2.74 billion. Shareholders would receive a 64% premium via cash and dividends.

reuters

2026-02-26

Univar, Ingredion sign pharmaceutical distribution deal for US, Canada

2026-03-11

Univar, SI Group Expand EMEA Distribution Partnership for Performance Additives

2026-04-14

Unilever Bets Big on Gummies as Next Frontier in Wellness

2026-04-27

Hungary's MOL Says Talks on NIS Acquisition Ongoing

2026-05-14

Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid